InNexus Biotechnology (InNexus Biotechnology) Net Change in Cash : $0.02 Mil (TTM As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

InNexus Biotechnology's Net Change in Cash for the three months ended in Mar. 2011 was $-0.07 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2011 was $0.02 Mil.

InNexus Biotechnology Net Change in Cash Historical Data

The historical data trend for InNexus Biotechnology's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Net Change in Cash Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Net Change in Cash

Get a 7-Day Free Trial

0.45

2.13

0.26

-2.66

-0.12

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Net Change in Cash	Get a 7-Day Free Trial															-	-	0.02	0.08	-0.07

InNexus Biotechnology Net Change in Cash Calculation

InNexus Biotechnology's Net Change in Cash for the fiscal year that ended in Jun. 2010 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-1.533	+	-0.047	+	1.461	+	0
	=	-0.12

InNexus Biotechnology's Net Change in Cash for the quarter that ended in Mar. 2011

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.118 + 0 + 0.048 + 0

= -0.07

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InNexus Biotechnology Net Change in Cash Related Terms
Thank you for viewing the detailed overview of InNexus Biotechnology's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Net Change in Cash

Comparable Companies

ONTX TSXV:APC APOP BTHE BOM:532871 GLPH AURX PTEO TSXV:PBS TIKRF NVIV BRTX TSXV:COT AKAOQ ATMS CAPS HSTC BOM:542765 MNTMD TSXV:MFS

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines